AAPL vs GSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Apr 03, 2026

AAPL

60.1
AI Score
VS
GSK Wins

GSK

60.9
AI Score

Investment Advisor Scores

AAPL

60score
Recommendation
BUY

GSK

61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric AAPL GSK Winner
Forward P/E 29.6736 22.1729 GSK
PEG Ratio 2.2707 0.4986 GSK
Revenue Growth 15.7% 6.2% AAPL
Earnings Growth 18.3% 54.7% GSK
Tradestie Score 60.1/100 60.9/100 GSK
Profit Margin 27.0% 17.5% AAPL
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, GSK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.